Cross Country Healthcare falls amid report on FTC review of Aya deal (CCRN:NASDAQ)

Core Viewpoint - Cross Country Healthcare (NASDAQ: CCRN) experienced a 5% decline following news regarding the Federal Trade Commission's (FTC) review of its proposed sale to Aya Healthcare, valued at $615 million [2] Group 1 - The FTC is currently conducting a review of the planned transaction by deposing third parties involved in the process [2]